Doubts raised over cancer vaccine study

doi:10.1136/bmj.323.7306.184/c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Annette Tuffs

Heidelberg

A prizewinning German study claiming to have found a safe and effective vaccine for kidney cancer has been heavily criticised by doctors who say that the research data may have been manipulated and that the treatment could even be dangerous.

Alexander Kugler, a senior registrar in the urology department of Göttingen University Hospital, and Gernot Stuhler, an oncologist from Tübingen University, treated 17 patients with metastasising kidney cancer with a vaccine made from a hybrid of cancer and immune cells. Their study, published in March last year, reported that after …